How would you like your name to appear on your certificate?

Profession

What activities did you attend at the event?

November 1 - AASLD/ILTS Transplant Course

November 1-2 - Postgraduate Course

November 3 - Hepatology Associates Course

Agreement

By completing this form, you attest that you have participated in all selected activities in thier entirety.

I agree

Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.

Please rate the following:

The program was relevant to my work.

Content matched stated objectives.

Usefulness of handouts/AV.

Quality of facilities.

If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situtation):

If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:

Having completed the activity, please rate your ability to meet each of the following objectives:

Define the role and cost-effectiveness of intensive care utilization

Critically evaluate the evidence to support the management of common early complications including acute cellular rejection and hepatic artery thrombosis

Define effective diagnostic pathways for graft dysfunction

Determine what could or should change in patient management beyond the first 10 years

Discuss new therapies for patients with liver disease

Discuss new techniques available for diagnosis of liver disease

Develop an appreciation of prospects for future therapies that may become available for patients with liver disease

Discuss the current nonalcoholic steatohepatitis (NASH) practice guidelines and appropriate, patient specific strategies to treat NASH & nonalcoholic fatty liver disease (NAFLD)

Describe patient selection indication for liver biopsy or a non-invasive alternative to stage fibrosis

Discuss controversial decisions with transplant patient selection and organ allocation including split vs full liver transplant

Identify appropriate strategies to manage difficult HCV treatment side effects

Please answer the following:

Do you believe this activity was appropriate for the scope of your professional activities?

Was the educational content scientifically sound?

If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?

Was the mode of education effective to learning?

If you answered "No" to any of the above questions, please explain.

Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?

If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):

Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?

If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):

How much did you learn as a result of this education program?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?

What problems are your patients/clients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

Basic

Intermediate

Advanced

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?

Additional comments: